Enzyme company BiOWiSH Technologies has relocated its corporate headquarters from Australia to the United States in order to better reach its two key geographic markets of North America and Europe, according to a company press release.

The new headquarters will be in Chicago, Ill., while the former headquarters in Sydney, Australia, will serve as the hub of BiOWiSH Technologies’ Asia-Pacific operations. All manufacturing continues in the company’s Bangkok, Thailand, production facility.


The company’s core product is BiOWiSH, a proprietary technology that accelerates enzymatic bio-chemical reactions. The product has been used in livestock production in two ways: as a sanitizing solution for cleaning the animal’s living environment, and as a feed additive to improve food conversion ratios. The company is working toward approval for using the product as a feed additive in the United States.